Androgen-Deprivation Therapy For Prostate Cancer May Increase Risk Of Alzheimer’s.

eports in “Quick Study” on research (12/22) published in the Journal of Clinical Oncology that suggests that androgen-deprivation therapy for prostate cancer may increase the risk of Alzheimer’s. Investigators “analyzed data on 16,888 men who had prostate cancer, including 2,397 who were treated with androgen-deprivation therapy.” Patients “treated with androgen-deprivation therapy were nearly twice as likely as the others to have developed Alzheimer’s, and those who had been given the hormone treatment for at least a year had more than double the risk for Alzheimer’s, compared with men who did not” receive ADT. https://www.washingtonpost.com/national/health-science/one-type-of-prostate-cancer-treatment-may-increase-chances-of-alzheimers/2015/12/18/aaa400a0-a4ed-11e5-9c4e-be37f66848bb_story.html